Research & Reports

Whitepapers, research reports and market data

#Overactive Bladder ×

Research & Reports

Aug 23, 2026•1 min read

Mirabegron Study for OAB Completed

Astellas Pharma's mirabegron study for overactive bladder in China is completed. The study evaluated efficacy and safety of mirabegron.